Abstract
Subcutaneous growth of immunogenic chemically induced rat sarcomata and a hepatoma was restricted when cells were injected into syngeneic animals in admixture with MER. Rats rejecting mixed inocula were immune to further challenge with the same tumour. Growth of a chemically induced mammary carcinoma which lacks detectable immunogenicity was suppressed when low cell inocula were injected in admixture with MER or intact BCG organisms, although animals were not immune to re-challenge. These studies indicate that clinically MER may be a suitable alternative to BCG for contact suppression of tumour growth or incorporation into tumour cell:adjuvant vaccines for active immunotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Hopper, D., Pimm, M. & Baldwin, R. Methanol extraction residue of BCG in the treatment of transplanted rat tumours. Br J Cancer 31, 176–181 (1975). https://doi.org/10.1038/bjc.1975.23
Issue Date:
DOI: https://doi.org/10.1038/bjc.1975.23
This article is cited by
-
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions
World Journal of Surgery (1977)
-
Vertical transmission of tumour resistance in guinea pigs
Nature (1976)
-
Silica abrogation of mycobacterial adjuvant contact suppression of tumor growth in rats and athymic mice
Cancer Immunology Immunotherapy (1976)